Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26686313

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Feb 27
First author
Forbes JF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Feb 27;387(10021):819-21. doi: 10.1016/S0140-6736(15)01219-2.
    note
    Source null
    related pmid
    26686312
    relationship
    Comment in

Authors and identifiers

  1. name
    Forbes JF
    type
    Author
  2. name
    Sestak I
    type
    Author
  3. name
    Howell A
    type
    Author
  4. name
    Bonanni B
    type
    Author
  5. name
    Bundred N
    type
    Author
  6. name
    Levy C
    type
    Author
  7. name
    von Minckwitz G
    type
    Author
  8. name
    Eiermann W
    type
    Author
  9. name
    Neven P
    type
    Author
  10. name
    Stierer M
    type
    Author
  11. name
    Holcombe C
    type
    Author
  12. name
    Coleman RE
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Forbes JF
    type
    Author
  2. name
    Sestak I
    type
    Author
  3. name
    Howell A
    type
    Author
  4. name
    Bonanni B
    type
    Author
  5. name
    Bundred N
    type
    Author
  6. name
    Levy C
    type
    Author
  7. name
    von Minckwitz G
    type
    Author
  8. name
    Eiermann W
    type
    Author
  9. name
    Neven P
    type
    Author
  10. name
    Stierer M
    type
    Author
  11. name
    Holcombe C
    type
    Author
  12. name
    Coleman RE
    type
    Author
bibliography ids
  1. nci-bib-2d759461e4ad6433937c9b77
book metadata
content sha256
80027da0771090c7bb20aaf1772604705ca25591a758e66e5fcb9a7b567ba4e1
document type
citation
dois
  1. 10.1016/S0140-6736(15)01129-0
electronic publication date
display
2015 Dec 11
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26686313
immutable id
pubmed:26686313@80027da0771090c7bb20aaf1772604705ca25591a758e66e5fcb9a7b567ba4e1
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10021
name
Lancet (London, England)
nlm unique id
2985213R
pages
866-73
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Feb 27;387(10021):819-21. doi: 10.1016/S0140-6736(15)01219-2.
    note
    Source null
    related pmid
    26686312
    relationship
    Comment in
outcomes validated
false
pmid
26686313
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
9da438f0b6a9fc4809ba27bdd3ff11407a245cbeec62a9fc30bdc2b73670c422
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Feb 27
precision
day
year
2016
publication types
  1. Comparative Study
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26686313/
title
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.

Preserved source evidence · Not medical advice